Quote:

---

would it be a stretch to think Gilead might have had some kind of, ahem, 'agreement' with our former CRO to do whatever it took to keep us off the market as long as possible?

---

My thought from the beginning if you throw a few 100 million people getting Remdesivir into the mix. To keep LL out of HIV and therefore out of the Pandemic, that would be worth money and maybe not just to Gilead. Then Amarex's side of the story would be worth listening to.

The more I think about the HIV experts being consulted the I think the FDA wants to work with us to get LL approved.